Login / Signup

Letter: A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma.

Abdur RahmanIvan D Lozada-MartinezSabrina RahmanA H M AtaullahKaren Muñoz-BaezLuis Rafael Moscote-SalazarAmit AgrawalMd Moshiur Rahman
Published in: Neurosurgery (2021)
Keyphrases
  • phase ii
  • clinical trial
  • open label
  • phase iii
  • multiple sclerosis
  • placebo controlled
  • double blind
  • study protocol
  • randomized controlled trial